Pelliciari, D. H. S., Reis, C. R. A. and Bordini, C. A. (2024) “Should anti-CGRP monoclonal antibodies always be the drug of first choice for migraine prophylaxis in Brazil? – a pharmacoeconomic study”, Headache Medicine, 15(Supplement), p. 98. Available at: https://headachemedicine.com.br/index.php/hm/article/view/1230 (Accessed: 16 October 2024).